Vilon
Khavinson dipeptide. Immune and longevity research; older-population focus.
- Half-life
- Not established
- Out of system
- —
- Route
- Subcutaneous
- Level
- Intermediate
What Vilon is used for
- Khavinson dipeptide — immune + longevity research
- Studied in older-population thymic function
How it's typically used
Research range: 5 mg subcutaneous daily for a 10-day course.
What to watch for
- Very limited Western evidence
- Subtle, cumulative effects
- Sourcing quality matters
About Longevity
- What they are
- Compounds studied for cellular ageing — mitochondrial function, senescent-cell clearance, telomere and autophagy pathways.
- How they're run
- Mixed routes: some injected in short annual or biannual courses, others taken orally every day.
- What to watch
- Endpoints here are measured in decades, so nobody has human outcome data. Bloodwork and function markers are the only feedback you will get in a realistic timeframe.
Full guide
Vilon: A Tracking Guide for a Short Khavinson Dipeptide
What Vilon is, where the research comes from, realistic expectations, and how to track a course if you choose to run one.
Other longevity
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.